Management of toxicities of combined modality therapy for intrathoracic malignancies

T. Weakland, Jr Wagner H.

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Background: Combined radiation and chemotherapy for intrathoracic tumors can produce appreciable morbidity. Apprehension about the severity of these toxicities may inhibit optimal patient care. Methods: The literature on recognition, diagnosis, prophylaxis, and management of these toxicities is reviewed and combined with the experiences of the authors to produce management recommendations. Results: Toxicities include acute and chronic esophagitis, early and late pneumonitis with fibrosis, myelosuppression, and neurologic deficits. Measures are available to minimize their severity and to reduce their impact on the patient. Conclusions: The morbidity of combined radiation and chemotherapy patients with intrathoracic tumors can be minimized by recognizing potential toxicities and by applying appropriate prophylactic and management measures.

Original languageEnglish (US)
Pages (from-to)329-335
Number of pages7
JournalCancer Control
Volume3
Issue number4
DOIs
StatePublished - Jan 1 1996

Fingerprint

Combined Modality Therapy
Background Radiation
Morbidity
Drug Therapy
Esophagitis
Neurologic Manifestations
Neoplasms
Pneumonia
Patient Care
Fibrosis
Radiation

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

@article{710bc3959b7941a9a82f43c4f0d87b1a,
title = "Management of toxicities of combined modality therapy for intrathoracic malignancies",
abstract = "Background: Combined radiation and chemotherapy for intrathoracic tumors can produce appreciable morbidity. Apprehension about the severity of these toxicities may inhibit optimal patient care. Methods: The literature on recognition, diagnosis, prophylaxis, and management of these toxicities is reviewed and combined with the experiences of the authors to produce management recommendations. Results: Toxicities include acute and chronic esophagitis, early and late pneumonitis with fibrosis, myelosuppression, and neurologic deficits. Measures are available to minimize their severity and to reduce their impact on the patient. Conclusions: The morbidity of combined radiation and chemotherapy patients with intrathoracic tumors can be minimized by recognizing potential toxicities and by applying appropriate prophylactic and management measures.",
author = "T. Weakland and {Wagner H.}, Jr",
year = "1996",
month = "1",
day = "1",
doi = "10.1177/107327489600300404",
language = "English (US)",
volume = "3",
pages = "329--335",
journal = "Cancer Control",
issn = "1073-2748",
publisher = "H. Lee Moffitt Cancer Center and Research Institute",
number = "4",

}

Management of toxicities of combined modality therapy for intrathoracic malignancies. / Weakland, T.; Wagner H., Jr.

In: Cancer Control, Vol. 3, No. 4, 01.01.1996, p. 329-335.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Management of toxicities of combined modality therapy for intrathoracic malignancies

AU - Weakland, T.

AU - Wagner H., Jr

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Background: Combined radiation and chemotherapy for intrathoracic tumors can produce appreciable morbidity. Apprehension about the severity of these toxicities may inhibit optimal patient care. Methods: The literature on recognition, diagnosis, prophylaxis, and management of these toxicities is reviewed and combined with the experiences of the authors to produce management recommendations. Results: Toxicities include acute and chronic esophagitis, early and late pneumonitis with fibrosis, myelosuppression, and neurologic deficits. Measures are available to minimize their severity and to reduce their impact on the patient. Conclusions: The morbidity of combined radiation and chemotherapy patients with intrathoracic tumors can be minimized by recognizing potential toxicities and by applying appropriate prophylactic and management measures.

AB - Background: Combined radiation and chemotherapy for intrathoracic tumors can produce appreciable morbidity. Apprehension about the severity of these toxicities may inhibit optimal patient care. Methods: The literature on recognition, diagnosis, prophylaxis, and management of these toxicities is reviewed and combined with the experiences of the authors to produce management recommendations. Results: Toxicities include acute and chronic esophagitis, early and late pneumonitis with fibrosis, myelosuppression, and neurologic deficits. Measures are available to minimize their severity and to reduce their impact on the patient. Conclusions: The morbidity of combined radiation and chemotherapy patients with intrathoracic tumors can be minimized by recognizing potential toxicities and by applying appropriate prophylactic and management measures.

UR - http://www.scopus.com/inward/record.url?scp=0029761721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029761721&partnerID=8YFLogxK

U2 - 10.1177/107327489600300404

DO - 10.1177/107327489600300404

M3 - Review article

AN - SCOPUS:0029761721

VL - 3

SP - 329

EP - 335

JO - Cancer Control

JF - Cancer Control

SN - 1073-2748

IS - 4

ER -